Ocuphire Pharma, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.11 | -$0.11 | -$0.11 |
Q2 2024 | 0 | -$0.26 | -$0.26 | -$0.26 |
Q3 2024 | 2 | -$0.26 | -$0.26 | -$0.26 |
Q4 2024 | 0 | -$0.04 | -$0.04 | -$0.04 |
Q1 2025 | 1 | -$0.29 | -$0.29 | -$0.29 |
Q2 2025 | 1 | -$0.27 | -$0.27 | -$0.27 |
Q3 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
Q4 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
Ocuphire Pharma, Inc. Earnings Date And Information
Ocuphire Pharma, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.3 earnings per share for the quarter, missing analysts' consensus estimates of $-0.29 by $0.01. The company had revenue of 1.11 M for the quarter and had revenue of 19.05 M for the year. Ocuphire Pharma, Inc. has generated $0 earnings per share over the last year ($-0.46 diluted earnings per share) and currently has a price-to-earnings ratio of -2.4. Ocuphire Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based on prior year's report dates.
Ocuphire Pharma, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/13/2024 | Q2 2024 | -$0.29 | -$0.30 | -0.01 | $2.45 M | $1.11 M |
03/29/2024 | Q1 2024 | -$0.29 | $1.71 M | |||
12/29/2023 | Q4 2023 | -$0.21 | $1.69 M | |||
11/13/2023 | Q3 2023 | -$0.22 | $0.26 | 0.48 | $3.03 M | $11.94 M |
08/11/2023 | Q2 2023 | -$0.36 | -$0.24 | 0.12 | $2.43 M | $3.67 M |
05/15/2023 | Q1 2023 | -$0.24 | -$0.26 | -0.02 | $1.75 M | |
03/30/2023 | Q4 2022 | $0.97 | $1.63 | 0.66 | $39.85 M | |
11/04/2022 | Q3 2022 | -$0.30 | -$0.22 | 0.08 | $0 | |
08/12/2022 | Q2 2022 | -$0.37 | -$0.25 | 0.12 | $0 | |
05/13/2022 | Q1 2022 | -$0.33 | -$0.35 | -0.02 | $0 | |
03/24/2022 | Q4 2021 | -$0.29 | -$0.36 | -0.07 | $-589,000 | |
11/12/2021 | Q3 2021 | -$0.36 | -$0.25 | 0.11 | $638,416 | $489,000 |
08/12/2021 | Q2 2021 | -$0.36 | -$0.52 | -0.16 | $100,000 | |
05/07/2021 | Q1 2021 | -$0.37 | -$3.57 | -3.2 | $0 | |
03/10/2021 | Q4 2020 | -$3.74 | $0 | |||
10/29/2020 | Q3 2020 | -$0.18 | $0 | |||
08/14/2020 | Q2 2020 | -$0.23 | $0 | |||
05/07/2020 | Q1 2020 | -$0.44 | $1.15 M | |||
02/21/2020 | Q4 2019 | -$0.71 | $0 | |||
11/06/2019 | Q3 2019 | -$2.16 | -$0.66 | 1.5 | $0 |
Ocuphire Pharma, Inc. Earnings: Frequently Asked Questions
-
When is Ocuphire Pharma, Inc.'s earnings date?
Ocuphire Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based off last year's report dates.
-
How can I listen to Ocuphire Pharma, Inc.'s earnings conference call?
The conference call for Ocuphire Pharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Ocuphire Pharma, Inc.'s conference call transcript?
The conference call transcript for Ocuphire Pharma, Inc.'s latest earnings report can be read online.
-
How much revenue does Ocuphire Pharma, Inc. generate each year?
Ocuphire Pharma, Inc. (:OCUP) has a recorded annual revenue of $19.05 M.
-
How much profit does Ocuphire Pharma, Inc. generate each year?
Ocuphire Pharma, Inc. (:OCUP) has a recorded net income of $19.05 M. Ocuphire Pharma, Inc. has generated $-0.46 earnings per share over the last four quarters.
-
What is Ocuphire Pharma, Inc.'s price-to-earnings ratio?
Ocuphire Pharma, Inc. (:OCUP) has a price-to-earnings ratio of -2.4 and price/earnings-to-growth ratio is 0.02.